Who can use VANFLYTA(Quizartinib)?

Quizartinib is a kinase inhibitor indicated for use in combination with standard cytarabine and anthracycline induction chemotherapy and cytarabine consolidation chemotherapy, and as maintenance monotherapy after consolidation chemotherapy, for the treatment of newly diagnosed adult patients with acute myeloid leukemia (AML) who are positive for FLT3 internal tandem duplication (ITD) as detected by an FDA-approved test.

Related Columns

Quizartinib(VANFLYTA)

VANFLYTA is indicated for adult patients with newly diagnosed Acute Myeloid...

WeChat Scan
Free Inquiry

What are the Indications of Quizartinib?

Quizartinib is an innovative kinase inhibitor that received its first approval in the United States in 2023.What are the Indications of Quizartinib?Primary Therapeutic AreaQuizartinib is a kinase inhi...

Quizartinib instructions, medical insurance, price, efficacy, side effects

Quizartinib is a drug for the treatment of specific leukemias, which has attracted widespread attention in the international medical field. This article will conduct an in-depth discussion on the...

Indications of Quizartinib

Quizartinib is a targeted therapy for acute myeloid leukemia caused by specific gene mutations. It is mainly used to treat relapsed or refractory FLT3-ITD mutation-positive AML and works by inhib...